CTHRC1 and cancer: Nevertheless, we found that neutralizing CTHRC1 completely reversed the activation of PSCs (migration/invasion/ECM secretion) and dramatically hindered the differentiation of PSCs to myCAFs, as well as blocked the pro-tumoral effects mediated by activated PSCs (e.g., cancer proliferation).